Details

NameSymbolSector
AJANTA PHARMA LTD.AJANTPHARMPharmaceuticals
Open
2822
High
2825
Low
2740.8
Close
2756
Volume
45413
Exchange
nse
Time
28-Apr-2026

Outlook

Score:  

3.75

Rating:  

FAIR

Candlestick Pattern

Candle pattern of Ajanta Pharma is  
Opening Marubozu
Estimated Stoploss of Ajanta Pharma is ₹  
2825
Ajanta Pharma has a  
Bearishℹ
 pattern. 
Formation of  
Opening Marubozu
 candle pattern indicates Ajanta Pharma has chances of  
Continuationℹ
 of the current trend. 

Trend

Ajanta Pharma is in  
Sideways trendℹ
. 
Price of Ajanta Pharma is  
Downℹ
 by  

3.8

%. 
Target
Buy @ 

2671.76

Sell @ 

3081.42

Current @ 

2756

Volume

The trade volumes of Ajanta Pharma have become  
Deficientℹ
The volume trend for Ajanta Pharma is  
Bearishℹ
, but the participants are  
Weak Sellersℹ
The trade volume of Ajanta Pharma is  

Down

 by  

57.1

% 

Valuation

The current market price of Ajanta Pharma is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 5014cr and total assets worth ₹ 5014cr, the balance sheet of Ajanta Pharma is:  
Balancedℹ
. 
Cashflow
Ajanta Pharma has  
Maintainedℹ
 cash flow because there is  

Surplus

 of  

₹ 47cr

. It is  
Upℹ
 by  

123.5

%. 

(*Mar 2025)

51.06% i.e. ₹ 1157cr earned in operatingℹ
16.59% i.e. ₹ 376cr spent in investingℹ
32.35% i.e. ₹ 733cr spent in financingℹ
0% in otherℹ
Ajanta Pharma has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 200cr

. It is  
Downℹ
 by  

261.29

%. 

(*Mar 2024)

41.29% i.e. ₹ 785cr earned in operatingℹ
3.42% i.e. ₹ 65cr earned in investingℹ
55.29% i.e. ₹ 1051cr spent in financingℹ
0% in otherℹ
Income
The income of Ajanta Pharma is  

₹ 1413cr

 and  

Profit

 is :  

₹ 260cr

(*Sep 2025)

Ajanta Pharma Profit is up by:  

1.96

% and Income is Up by:  

6.4

% 

(*Sep 2025)

The income of Ajanta Pharma is  

₹ 1328cr

 and  

Profit

 is :  

₹ 255cr

(*Jun 2025)

Ajanta Pharma Profit is up by:  

13.33

% and Income is Up by:  

11.78

% 

(*Jun 2025)

The income of Ajanta Pharma is  

₹ 1188cr

 and  

Profit

 is :  

₹ 225cr

(*Mar 2025)

Ajanta Pharma Profit is down by:  

3.02

% and Income is Up by:  

1.02

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.